PT-141 (Bremelanotide) 10mg Research Peptide
PT-141, also known by its INN name Bremelanotide, is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that acts as a non-selective agonist at melanocortin receptors MC1R, MC3R, MC4R, and MC5R. It is unusually well characterized among research peptides, giving researchers a thoroughly documented pharmacological profile. Unlike PDE5 inhibitors, PT-141 acts centrally through the melanocortin system rather than through vascular mechanisms. This 10mg vial provides research-grade PT-141 at ≥99% purity, HPLC and MS/MS verified per batch.
Research Background
PT-141 was originally derived from Melanotan II and identified as an active metabolite with CNS-mediated sexual arousal effects in animal models. Controlled clinical studies have characterized its central melanocortin activity, providing reference data for MC4R-mediated signalling research. Research has also explored PT-141’s MC4R-mediated effects on energy homeostasis, mood, and inflammation — areas relevant to the broader melanocortin receptor research literature.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 10mg per vial
- Storage: −20°C, protected from light
- CAS Number: 189691-06-3
- Molecular Weight: 1025.2 Da
Certificate of Analysis
All PT-141 vials are third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
